By establishing a novel prognostic gene signature, delineating PTK6’s regulatory network, and demonstrating its influence on melanoma cell proliferation and invasion, we identify PTK6 as a promising biomarker and potential therapeutic target for CM. Here, PTK6 is linked to melanoma.